- Home
- NMRA vs AFRI Comparison
NMRA vs AFRI Comparison
Compare NMRA & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- AFRI
- Stock Information
- Founded
- NMRA 2019
- AFRI 1943
- Country
- NMRA United States
- AFRI Gibraltar
- Employees
- NMRA N/A
- AFRI N/A
- Industry
- NMRA
- AFRI Packaged Foods
- Sector
- NMRA
- AFRI Consumer Staples
- Exchange
- NMRA Nasdaq
- AFRI Nasdaq
- Market Cap
- NMRA 268.5M
- AFRI 207.7M
- IPO Year
- NMRA 2023
- AFRI N/A
- Fundamental
- Price
- NMRA $1.52
- AFRI $8.82
- Analyst Decision
- NMRA Hold
- AFRI
- Analyst Count
- NMRA 8
- AFRI 0
- Target Price
- NMRA $5.83
- AFRI N/A
- AVG Volume (30 Days)
- NMRA 376.8K
- AFRI 13.1K
- Earning Date
- NMRA 11-11-2025
- AFRI 04-30-2025
- Dividend Yield
- NMRA N/A
- AFRI N/A
- EPS Growth
- NMRA N/A
- AFRI N/A
- EPS
- NMRA N/A
- AFRI N/A
- Revenue
- NMRA N/A
- AFRI $274,223,000.00
- Revenue This Year
- NMRA N/A
- AFRI N/A
- Revenue Next Year
- NMRA N/A
- AFRI N/A
- P/E Ratio
- NMRA N/A
- AFRI N/A
- Revenue Growth
- NMRA N/A
- AFRI N/A
- 52 Week Low
- NMRA $0.61
- AFRI $7.47
- 52 Week High
- NMRA $17.19
- AFRI $11.74
- Technical
- Relative Strength Index (RSI)
- NMRA 42.36
- AFRI 64.98
- Support Level
- NMRA $1.42
- AFRI $8.21
- Resistance Level
- NMRA $1.59
- AFRI $8.87
- Average True Range (ATR)
- NMRA 0.10
- AFRI 0.37
- MACD
- NMRA -0.03
- AFRI 0.01
- Stochastic Oscillator
- NMRA 21.69
- AFRI 70.85
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.